Trial Profile
A Randomized, Double-blind, Placebo-controlled Trial to Determine the Effects and Duration of Action of Tiotropium Bromide on Pulmonary Function in Persons With SCI
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 11 Sep 2020 Status changed from recruiting to completed.
- 02 Mar 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 02 Mar 2018 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.